JP2018087246A5 - - Google Patents

Download PDF

Info

Publication number
JP2018087246A5
JP2018087246A5 JP2018035032A JP2018035032A JP2018087246A5 JP 2018087246 A5 JP2018087246 A5 JP 2018087246A5 JP 2018035032 A JP2018035032 A JP 2018035032A JP 2018035032 A JP2018035032 A JP 2018035032A JP 2018087246 A5 JP2018087246 A5 JP 2018087246A5
Authority
JP
Japan
Prior art keywords
extract
agents
formulation
subject
oral formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018035032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018087246A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018087246A publication Critical patent/JP2018087246A/ja
Publication of JP2018087246A5 publication Critical patent/JP2018087246A5/ja
Withdrawn legal-status Critical Current

Links

JP2018035032A 2011-03-14 2018-02-28 細胞浄化を促進するための経口製剤 Withdrawn JP2018087246A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161452478P 2011-03-14 2011-03-14
US61/452,478 2011-03-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013558154A Division JP6625792B2 (ja) 2011-03-14 2012-03-14 細胞浄化を促進するための経口製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019121344A Division JP2019154453A (ja) 2011-03-14 2019-06-28 細胞浄化を促進するための経口製剤

Publications (2)

Publication Number Publication Date
JP2018087246A JP2018087246A (ja) 2018-06-07
JP2018087246A5 true JP2018087246A5 (enExample) 2018-07-19

Family

ID=46831336

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013558154A Active JP6625792B2 (ja) 2011-03-14 2012-03-14 細胞浄化を促進するための経口製剤
JP2018035032A Withdrawn JP2018087246A (ja) 2011-03-14 2018-02-28 細胞浄化を促進するための経口製剤
JP2019121344A Pending JP2019154453A (ja) 2011-03-14 2019-06-28 細胞浄化を促進するための経口製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013558154A Active JP6625792B2 (ja) 2011-03-14 2012-03-14 細胞浄化を促進するための経口製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019121344A Pending JP2019154453A (ja) 2011-03-14 2019-06-28 細胞浄化を促進するための経口製剤

Country Status (7)

Country Link
US (3) US20130071369A1 (enExample)
EP (1) EP2686021B1 (enExample)
JP (3) JP6625792B2 (enExample)
KR (1) KR102090836B1 (enExample)
CN (1) CN103732258A (enExample)
SG (2) SG10201703576WA (enExample)
WO (1) WO2012125772A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492952B2 (en) 2010-08-30 2016-11-15 Endo-Surgery, Inc. Super-hydrophilic structures
US20120143228A1 (en) 2010-08-30 2012-06-07 Agency For Science Technology And Research Adhesive structure with stiff protrusions on adhesive surface
EP2797607B1 (en) 2011-12-29 2018-11-07 Ethicon, Inc. Adhesive structure with tissue piercing protrusions on its surface
US8969648B2 (en) 2012-04-06 2015-03-03 Ethicon, Inc. Blood clotting substrate and medical device
US8926881B2 (en) 2012-04-06 2015-01-06 DePuy Synthes Products, LLC Super-hydrophobic hierarchical structures, method of forming them and medical devices incorporating them
US9517249B2 (en) 2012-11-26 2016-12-13 Access Business Group International Llc Antioxidant dietary supplement and related method
WO2015030293A1 (ko) * 2013-08-30 2015-03-05 씨제이제일제당 (주) 포도 및 오미자 복합 추출물을 포함하는 대사증후군 관련 질환의 예방 또는 치료용 조성물
JPWO2015046486A1 (ja) * 2013-09-30 2017-03-09 サンスター株式会社 肥満抑制組成物
WO2016037971A1 (en) 2014-09-08 2016-03-17 Bios Line S.P.A. Compositions comprising glucosinolates precursors of sulforaphane in combination with extracts of rosemary
CN104382983A (zh) * 2014-11-28 2015-03-04 哈尔滨墨医生物技术有限公司 一种藏虫草提取物软胶囊及其制备方法
FR3046935B1 (fr) * 2016-01-21 2020-12-25 Ly Eang Hay Composition a visee detoxifiante pour administration par voie orale et son procede de preparation
JP2016121178A (ja) * 2016-03-03 2016-07-07 サンスター株式会社 抗酸化機能亢進剤
CN111194215B (zh) 2017-08-04 2024-03-01 斯基霍克疗法公司 用于调节剪接的方法和组合物
WO2020163405A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7603595B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
US11541094B2 (en) 2019-08-06 2023-01-03 Healthrite Partners, LLC Formulations for treating metabolic syndrome and increasing energy levels
US11484563B2 (en) * 2020-01-13 2022-11-01 Lifevantage Corporation Compositions and methods for activating cellular signaling pathways
JP2023544118A (ja) 2020-09-24 2023-10-20 マース インコーポレーテッド 食品組成物およびその用途
US11541116B1 (en) 2022-01-07 2023-01-03 Kojin Therapeutics, Inc. Methods and compositions for inducing ferroptosis in vivo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2346325A (en) * 1999-02-02 2000-08-09 Wassen Int Ltd Formulation comprising a brassica extract or sulforaphane and resveratrol
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
EP1813269A1 (en) * 2004-10-22 2007-08-01 Kirin Beer Kabushiki Kaisha TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO
CA2625433A1 (en) * 2005-10-11 2007-04-19 Lycored Ltd. Carotenoid oxidation products as chemopreventive and chemotherapeutic agents
US8017147B2 (en) * 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20080305096A1 (en) * 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
US20110091587A1 (en) * 2007-09-11 2011-04-21 Joslin Diabetes Center, Inc. Phase ii detoxification and antioxidant activity
EP2418965B1 (en) * 2009-04-17 2016-06-29 DSM IP Assets B.V. Hydroxytyrosol combinations for enhancing mitochondrial function and energy production.
EP2575839B1 (en) * 2010-05-24 2016-11-02 NSE Products, Inc. Oral formulations for counteracting effects of aging

Similar Documents

Publication Publication Date Title
JP2018087246A5 (enExample)
JP2014510081A5 (enExample)
RU2479313C2 (ru) Способ лечения или профилактики заболеваний дыхательных путей, включающий введение холекальциферола
Braun et al. Herbs and natural supplements, volume 2: An evidence-based guide
US20050266018A1 (en) Nutraceutical compositions with mangosteen
TW200843726A (en) Agent for relief or prevention of xerostomia
CN107708688A (zh) 使用天然化合物和/或饮食治疗炎症的方法
Abad et al. Effect of Matricaria chamomilla hydroalcoholic extract on cisplatin-induced neuropathy in mice
NL2033616B1 (en) Anti-ageing supplement
Verma A study on medicinal herb Spinacia oleraceae Linn: Amaranthaceae
CN102716437B (zh) 一种萎缩性胃炎的中药组合物
US10946075B1 (en) Radioprotection, radiomitigation and radiorecovery
WO2020058817A1 (en) Pharmaceutical composition and process for its preparation
CN102000174A (zh) 一种美白中药内服配方
CN105764519A (zh) 用于治疗咳嗽的基于植物的组合物
BR112017025189B1 (pt) composições compreendendo extrato da casca do tronco de pinus pinaster, seu método de fabricação e usos das mesmas
CN107927738A (zh) 一种抗衰老保健食品及其制备工艺
US20180235904A1 (en) Cannabidiol compositions including mixtures and uses thereof
CN102631525B (zh) 一种具有降血压功能的保健品及其制备方法
CN102727858A (zh) 一种治疗头痛、偏头痛的药物组合物及其制备方法和用途
RU2206331C2 (ru) Фитокомплекс на основе сборов "фиторал-1", "фиторал-2" и "эковит" для лечения заболеваний желудочно-кишечного тракта, печени, сердечно-сосудистой и мочевыделительной системы диабета и паразитозов
CN101766666A (zh) 治疗心脑血管疾病的中药
ES2986705T3 (es) Extracto de aceituna adecuado para reducir el índice de masa corporal y la grasa visceral en sujetos con sobrepeso
RU2438688C1 (ru) Антигельминтное средство растительного происхождения
CN105998140A (zh) 红景天含片